Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -276,852 | -205,451 | -141,440 | -88,948 | -356,388 |
| Depreciation Amortization | 10,640 | 7,423 | 4,335 | 1,995 | 7,321 |
| Income taxes - deferred | -155 | N/A | N/A | N/A | -1,415 |
| Accounts receivable | -11,219 | -10,845 | -10,388 | -8,358 | -11,114 |
| Other Working Capital | -32,064 | -31,224 | -32,609 | -45,178 | 11,610 |
| Other Operating Activity | 76,360 | 56,629 | 38,642 | 32,547 | 99,570 |
| Operating Cash Flow | $-233,290 | $-183,468 | $-141,460 | $-107,942 | $-250,416 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,352 | 11,357 | 165,134 | 94,052 | 115,165 |
| PPE Investments | -3,227 | -2,160 | -1,876 | -806 | -20,012 |
| Investing Cash Flow | $-13,579 | $9,197 | $163,258 | $93,246 | $95,153 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 385,929 | 385,929 | N/A | N/A | N/A |
| Debt Repayment | -155,325 | -155,307 | -38 | -21 | -420 |
| Common Stock Issued | 42,282 | 20,028 | 10,734 | 6,077 | 201,282 |
| Common Stock Repurchased | -10,028 | -9,340 | -8,097 | -7,543 | -3,235 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 19,875 |
| Financing Cash Flow | $262,858 | $241,310 | $2,599 | $-1,487 | $217,502 |
| Exchange Rate Effect | 3,830 | 45 | -3,476 | -4,265 | 1,729 |
| Beginning Cash Position | 146,343 | 146,341 | 146,341 | 146,341 | 82,375 |
| End Cash Position | 166,162 | 213,425 | 167,262 | 125,893 | 146,343 |
| Net Cash Flow | $19,819 | $67,084 | $20,921 | $-20,448 | $63,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -233,290 | -183,468 | -141,460 | -107,942 | -250,416 |
| Capital Expenditure | -3,227 | -2,160 | -1,876 | -806 | -20,012 |
| Free Cash Flow | -236,517 | -185,628 | -143,336 | -108,748 | -270,428 |